EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity

Emanuela Amore iD, Vittoria Cenni iD, Manuela Piazzi iD, Michele Signore iD, Giulia Orlandi, Simona Neri iD, Stefano Biressi iD, Rosario Barone iD, Valentina Di Felice iD, Matilde Y Follo, Jessika Bertacchini, Carla Palumbo iD

Biomolecules · 2024

DOI: 10.3390/biom14101243 ↗

At a glance

Journal article in Biomolecules, 2024. Written by Emanuela Amore and 11 co-authors. Institution: Laboratorio Ramses, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy. Major MEDLINE topics: Cell Differentiation, Galectin 3, Myoblasts, Osteoblasts. Cited 5 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: FAR 2019 Interdepartmental Grant, awarded by the University of Modena and Reggio Emilia, MIUR-PRIN 2017, MIUR-PRIN 2017_RKWNJT.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Galectin-3 (Gal-3) is a pleiotropic lectin produced by most cell types, which regulates multiple cellular processes in various tissues. In bone, depending on its cellular localization, Gal-3 has a dual and opposite role. If, on the one hand, intracellular Gal-3 promotes bone formation, on the other, its circulating form affects bone remodeling, antagonizing osteoblast differentiation and increasing osteoclast activity. From an analysis of the secretome of cultured differentiating myoblasts, we interestingly found the presence of Gal-3. After that, we confirmed that Gal-3 was expressed and released in the extracellular environment from myoblast cells during their differentiation into myotubes, as well as after mechanical strain. An in vivo analysis revealed that Gal-3 was triggered by trained exercise and was specifically produced by fast muscle fibers. Speculating a role for this peptide in the muscle-to-bone cross talk, a direct co-culture in vitro system, simultaneously combining media that were obtained from differentiated myoblasts and osteoblast cells, confirmed that Gal-3 is a mediator of osteoblast differentiation. Molecular and proteomic analyses revealed that the secreted Gal-3 modulated the biochemical processes occurring in the early phases of bone formation, in particular impairing the activity of the STAT3 and PDK1/Akt signaling pathways and, at the same time, triggering that one of Notch. Circulating Gal-3 also affected the expression of the most common factors involved in osteogenetic processes, including BMP-2, -6, and -7. Intriguingly, Gal-3 was able to interfere with the ability of differentiating osteoblasts to interact with the components of the extracellular bone matrix, a crucial condition required for a proper osteoblast differentiation. All in all, our evidence lays the foundation for further studies to present this lectin as a novel myokine involved in muscle-to-bone crosstalk.

Subjects

MeSH terms (MEDLINE)

Cell DifferentiationGalectin 3MyoblastsOsteoblastsOsteogenesisProto-Oncogene Proteins c-aktAnimalsMaleMiceCell LineReceptors, NotchSignal TransductionSTAT3 Transcription Factor

Author keywords

AktNotchgalectinsmuscle-to-bone crosstalkmyokineproteomics

Substances

Galectin 3Proto-Oncogene Proteins c-aktReceptors, NotchSTAT3 Transcription FactorLgals3 protein, mouse

Authors and institutions

  • Laboratorio Ramses, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy.
  • CNR-Institute of Molecular Genetics, 40136 Bologna, Italy.
  • IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
  • RPPA Unit of Proteomics Area, Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy.
  • Medicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

ORCID profiles: Emanuela Amore, Vittoria Cenni, Manuela Piazzi, Michele Signore, Simona Neri, Stefano Biressi, Rosario Barone, Valentina Di Felice, Carla Palumbo

Funding

  • FAR 2019 Interdepartmental Grant, awarded by the University of Modena and Reggio Emilia
  • MIUR-PRIN 2017
  • MIUR-PRIN 2017_RKWNJT

Cite

APA

Amore, E., Cenni, V., Piazzi, M., Signore, M., Orlandi, G., Neri, S., Biressi, S., Barone, R., Di Felice, V., Follo, M. Y., Bertacchini, J., & Palumbo, C. (2024). Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity. Biomolecules. https://doi.org/10.3390/biom14101243

Vancouver

Amore E, Cenni V, Piazzi M, Signore M, Orlandi G, Neri S, et al. Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity. Biomolecules. 2024. doi:10.3390/biom14101243

BibTeX
@article{Amore2024,
  author = {Amore, Emanuela and Cenni, Vittoria and Piazzi, Manuela and Signore, Michele and Orlandi, Giulia and Neri, Simona and Biressi, Stefano and Barone, Rosario and Di Felice, Valentina and Follo, Matilde Y and Bertacchini, Jessika and Palumbo, Carla},
  title = {Myoblast-Derived Galectin 3 Impairs the Early Phases of Osteogenesis Affecting Notch and Akt Activity},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14101243}
}
Start for free →